0
Oversigt Update regarding Elicera Therpeutics ticker ELIC, see previous thread from 31/10 about the company:
First patient in on ELC-301 has completed and interim results of three patients is due Q1-2025, where safety and effect will already be measured, so according to CEO we might already see the anti-tumor effect at lowest dosage, which will be a high share price driver, and a 5 x share price rally H1 2025 would be possible given the already low valuation of the company.
https://www.redeye.se/video/event-presentation/1053807/elicera-therapeutics-ceo-jamal-el-mosleh-presents-at-redeye-investor-forum-in-gothenburg-nov-7-2024
here is link in Swedish where CEO presents the company and the latest clinical trial.
https://www.biostock.se/2024/11/eliceras-vd-en-av-de-storsta-milstolparna-i-var-historia/
Link in swedish to interview with CEO where he is very optimistic about the company.
https://discord.gg/SzwSQFE6SC link to community.
First patient in on ELC-301 has completed and interim results of three patients is due Q1-2025, where safety and effect will already be measured, so according to CEO we might already see the anti-tumor effect at lowest dosage, which will be a high share price driver, and a 5 x share price rally H1 2025 would be possible given the already low valuation of the company.
https://www.redeye.se/video/event-presentation/1053807/elicera-therapeutics-ceo-jamal-el-mosleh-presents-at-redeye-investor-forum-in-gothenburg-nov-7-2024
here is link in Swedish where CEO presents the company and the latest clinical trial.
https://www.biostock.se/2024/11/eliceras-vd-en-av-de-storsta-milstolparna-i-var-historia/
Link in swedish to interview with CEO where he is very optimistic about the company.
https://discord.gg/SzwSQFE6SC link to community.